Sincere Co., LTD. (7782.T)
JPY 524.0
(-1.32%)
JPY 524.0
(-1.32%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 391 Million JPY | 91.22% |
| 2022 | 129 Million JPY | 75.2% |
| 2021 | 134.31 Million JPY | -52.06% |
| 2020 | 232.66 Million JPY | 51.65% |
| 2019 | 168.33 Million JPY | 1208.73% |
| 2018 | 36.52 Million JPY | -95.1% |
| 2017 | 359.58 Million JPY | -61.1% |
| 2016 | 278.78 Million JPY | 115.31% |
| 2015 | 344.66 Million JPY | -22.37% |
| 2014 | 408.26 Million JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 130.78 Million JPY | 54.95% |
| 2024 Q1 | 88.19 Million JPY | -18.17% |
| 2023 Q3 | 97.53 Million JPY | 37.67% |
| 2023 Q4 | 98.92 Million JPY | 1.42% |
| 2023 FY | - JPY | 91.45% |
| 2023 Q1 | 98.93 Million JPY | 526.77% |
| 2023 Q2 | 70.84 Million JPY | -28.39% |
| 2022 Q2 | 81.05 Million JPY | 93.99% |
| 2022 Q1 | 41.78 Million JPY | 238.96% |
| 2022 Q4 | 15.78 Million JPY | -70.99% |
| 2022 FY | - JPY | 75.2% |
| 2022 Q3 | 54.41 Million JPY | -32.87% |
| 2021 FY | - JPY | -52.06% |
| 2021 Q3 | 46.87 Million JPY | 50.95% |
| 2021 Q4 | 12.32 Million JPY | -73.7% |
| 2021 Q1 | 15.18 Million JPY | -89.21% |
| 2021 Q2 | 31.05 Million JPY | 104.49% |
| 2020 Q3 | 65.37 Million JPY | 852.34% |
| 2020 Q1 | 16.22 Million JPY | -55.1% |
| 2020 Q4 | 140.75 Million JPY | 115.29% |
| 2020 FY | - JPY | 51.65% |
| 2020 Q2 | 6.86 Million JPY | -57.69% |
| 2019 Q3 | 47.86 Million JPY | -21.42% |
| 2019 Q1 | 5.46 Million JPY | -91.67% |
| 2019 FY | - JPY | 1208.73% |
| 2019 Q2 | 60.9 Million JPY | 1014.92% |
| 2019 Q4 | 36.13 Million JPY | -24.49% |
| 2018 Q1 | -64.61 Million JPY | -347.88% |
| 2018 Q4 | 65.59 Million JPY | 58.45% |
| 2018 FY | - JPY | -95.1% |
| 2018 Q3 | 41.39 Million JPY | 204.01% |
| 2018 Q2 | -39.8 Million JPY | 38.4% |
| 2017 Q2 | 49.79 Million JPY | -67.37% |
| 2017 FY | - JPY | -61.1% |
| 2017 Q1 | 152.57 Million JPY | 174.92% |
| 2017 Q4 | -14.42 Million JPY | -129.98% |
| 2017 Q3 | 48.11 Million JPY | -3.36% |
| 2016 Q4 | 55.49 Million JPY | 0.0% |
| 2016 FY | - JPY | 115.31% |
| 2016 Q3 | - JPY | 0.0% |
| 2015 FY | - JPY | -22.37% |
| 2014 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| JINS HOLDINGS Inc. | 10.26 Billion JPY | 96.189% |
| Medius Holdings Co., Ltd. | 3.86 Billion JPY | 89.878% |
| Ship Healthcare Holdings, Inc. | 31.88 Billion JPY | 98.774% |
| JTEC Corporation | 437.18 Million JPY | 10.563% |
| Hogy Medical Co.,Ltd. | 10.77 Billion JPY | 96.372% |
| Kawamoto Corporation | 944.44 Million JPY | 58.6% |
| Terumo Corporation | 219.66 Billion JPY | 99.822% |
| KAINOS Laboratories, Inc. | 1.05 Billion JPY | 62.966% |
| JAPAN EYEWEAR HOLDINGS CO LTD | 5.18 Billion JPY | 92.456% |
| Sysmex Corporation | 115.67 Billion JPY | 99.662% |
| JMS Co.,Ltd. | 3.44 Billion JPY | 88.654% |
| Nakanishi Inc. | 32.3 Billion JPY | 98.789% |
| Mani, Inc. | 10.69 Billion JPY | 96.345% |
| Olympus Corporation | 180.16 Billion JPY | 99.783% |
| HOYA Corporation | 260.44 Billion JPY | 99.85% |
| SEED Co.,Ltd. | 4.88 Billion JPY | 91.989% |
| Asahi Intecc Co., Ltd. | 31.85 Billion JPY | 98.773% |
| Medikit Co.,Ltd. | 6.31 Billion JPY | 93.813% |
| Daiken Medical Co., Ltd. | 1.65 Billion JPY | 76.409% |
| Menicon Co., Ltd. | 16.9 Billion JPY | 97.686% |
| Platz Co., Ltd. | 267.15 Million JPY | -46.359% |
| Paramount Bed Holdings Co., Ltd. | 23.4 Billion JPY | 98.33% |
| Shofu Inc. | 5.87 Billion JPY | 93.348% |
| Shigematsu Works Co., Ltd. | 1.38 Billion JPY | 71.774% |
| Nipro Corporation | 81.2 Billion JPY | 99.519% |
| ASO International, Inc. | 602.47 Million JPY | 35.101% |